Skip to main content
. 2023 May 24;31(3):275–286. doi: 10.32604/or.2023.028227

Table 4. Summary of groups with high negative-rate(R0) or high-expression rate(R2).

Classification PD-L1 TPS, n (%) Sum R0(95% CI) R2(95% CI)
<1% 1%~49% ≥50%
Well~ medium differentiation
&Clinical stages I~II
&LUADs
145 36 4 185 0.784(0.724–0.884) 0.022(0.000–0.430)
Well~ medium differentiation
&LUADs
&N0
138 36 5 179 0.771(0.709–0.833) 0.028(0.004–0.052)
No smoking
&LUADs
&M0
113 33 4 150 0.753(0.684–0.823) 0.027(0.001–0.053)
Well~ medium differentiation
&N0
&M0
173 44 7 224 0.772(0.717–0.828) 0.031(0.008–0.054)
Well~ medium differentiation
&Clinical stages I~II
184 48 10 242 0.760(0.706–0.814) 0.041(0.016–0.067)
N1~N3
& LUSC
15 10 15 40 0.375(0.218–0.532) 0.375(0.218–0.532)
Poor differentiation
&N3
7 9 13 29 0.241(0.076–0.407) 0.448(0.256–0.641)
Smoking
&N3
&M0
3 3 10 16 0.188(0.040–0.460) 0.625(0.359–0.891)

Note: R0 means the rate of being negative in PD-L1 detection, R2 means the rate of being high expression in PD-L1 detection.